Anafranil Tablet 25 mg is a tricyclic antidepressant used to treat depression and other psychiatric disorders. It is also used to treat obsessive-compulsive disorder (OCD). Anafranil Tablet 25 mg works by blocking certain chemical messengers in the brain that affect mood and emotion. It works by altering serotonin and norepinephrine levels in the brain.
Anafranil Tablet 25 mg is used to treat depression and other psychiatric disorders. It is also used to treat obsessive-compulsive disorder (OCD).
Anafranil Tablet 25 mg blocks the reuptake of serotonin and norepinephrine in the brain. This increases the amount of these two neurotransmitters available to be used by neurons, which in turn leads to an improved mood and well being.
Anafranil Tablet 25 mg usually takes 4-6 weeks for its full effect. However, some people may notice some improvement of their symptoms within a few days of starting the drug.
Anafranil Tablet 25 mg is rapidly absorbed from the gastrointestinal tract and reaches its maximum concentration in about three hours. It has a bioavailability of 84%.
Anafranil Tablet 25 mg is metabolized in the liver by deamination and hydroxylation and is primarily excreted in the urine as metabolites.
The usual initial adult dose of Anafranil Tablet 25 mg is 25 mg given 3 or 4 times daily. The daily dose may then be increased by 25-50 mg every week in divided doses up to a maximum of 250 mg/day. It can also be given as a single daily dose, taken at bedtime.
Anafranil Tablet 25 mg is provided as tablets and capsules that can be taken orally. It should be taken with food or a full glass of water to reduce the risk of stomach discomfort.
Common side effects of Anafranil Tablet 25 mg include fatigue, drowsiness, nausea, dizziness, dry mouth, constipation, and blurred vision. More serious side effects can include seizures, difficulty breathing, chest pain, fast or irregular heart beat, and confusion.
Anafranil Tablet 25 mg is generally well tolerated, but can be toxic if taken in large doses. Symptoms of toxicity include confusion, delirium, agitation, restlessness, increased heart rate, hypotension, seizures, and coma.
Patients taking Anafranil Tablet 25 mg should be monitored closely for suicidal thoughts or behavior, especially those with or at risk for depression. Patients should also be monitored for seizures, heart rhythm disturbances, and any other adverse reactions. Patients should contact their doctor if they experience any new or worsening symptoms while taking Anafranil Tablet 25 mg.
Anafranil Tablet 25 mg can interact with other medications including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and warfarin. It can also interact with alcohol, some herbal products, and certain foods. Patients should inform their doctor about all medications they are taking before taking Anafranil Tablet 25 mg.
Anafranil Tablet 25 mg may interact with some diseases, including epilepsy, seizure disorders, bipolar disorder, heart rhythm disturbances, and glaucoma. Patients should inform their doctor of any existing medical conditions before taking Anafranil Tablet 25 mg.
Anafranil Tablet 25 mg can interact with other medications including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and warfarin. Patients should inform their doctor about all medications they are taking before taking Anafranil Tablet 25 mg.
Alcohol and certain foods can interact with Anafranil Tablet 25 mg. Alcohol should be avoided when taking Anafranil Tablet 25 mg. Certain foods such as cheese, liver, and tyramine containing products should also be avoided. Patients should inform their doctor of any dietary changes before taking Anafranil Tablet 25 mg.
Anafranil Tablet 25 mg is classified as Pregnancy Category C. This means that it may not be safe for use by pregnant women. Patients should inform their doctor if they are pregnant or planning to become pregnant before taking Anafranil Tablet 25 mg.
Anafranil Tablet 25 mg is classified as Lactation Risk Category B. This means that it is unlikely to harm a nursing infant. Patients should inform their doctor if they are breastfeeding or planning to breastfeed before taking Anafranil Tablet 25 mg.
Symptoms of an acute overdose of Anafranil Tablet 25 mg can include confusion, delirium, agitation, restlessness, increased heart rate, hypotension, seizures, and coma. In case of an overdose, patients should seek immediate medical attention.
Anafranil Tablet 25 mg is contraindicated in patients with known hypersensitivity to the drug or its ingredients. It should also not be given to patients with glaucoma, seizure disorders, or a history of mania.
Anafranil Tablet 25 mg should be taken exactly as prescribed by the doctor. The usual initial adult dose of Anafranil Tablet 25 mg is 25 mg given 3 or 4 times daily. The daily dose may then be increased by 25-50 mg every week in divided doses up to a maximum of 250 mg/day. It can also be given as a single daily dose, taken at bedtime.
Anafranil Tablet 25 mg should be stored at room temperature, away from moisture and heat. It should be kept out of the reach of children.
Anafranil Tablet 25 mg has a volume of distribution of 0.9 L/kg.
Anafranil Tablet 25 mg has a half life of 16-36 hours.
Anafranil Tablet 25 mg has a clearance of 1.6 mL/minute/kg.
See in details version Anafranil Tablet 25 mg also Anafranil Tablet 25 mg in bangla